GLIMSI: A real-world, multicenter study assessing the effectiveness and safety of Sitagliptin + Glimepiride + Metformin FDC in Indian patients with Type 2 diabetes
GLIMSI:一项真实世界、多中心研究,旨在评估西格列汀+格列美脲+二甲双胍固定剂量复方制剂在印度2型糖尿病患者中的有效性和安全性
期刊:PLoS One
影响因子:2.6
doi:10.1371/journal.pone.0337107
Zaveri, Kunal; Kulkarni, Girish; Nair, Rathish; Shanmugan, Govarthanan; Dharmadhikari, Shubhada Amol; Makkar, R P S; Jalgaonkar, Rahul; Chatterjee, B D; Korukonda, Krishnaprasad